Trade Soligenix, Inc. - SNGX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.088 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023374% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001151% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.001 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.031 |
| Open | 2.901 |
| 1-Year Change | 409.84% |
| Day's Range | 2.881 - 2.971 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 20, 2024 | 2.941 | 0.040 | 1.38% | 2.901 | 2.971 | 2.881 |
| Dec 19, 2024 | 3.031 | -0.030 | -0.98% | 3.061 | 3.141 | 2.981 |
| Dec 18, 2024 | 3.121 | 0.010 | 0.32% | 3.111 | 3.141 | 3.091 |
| Dec 17, 2024 | 2.961 | -0.140 | -4.51% | 3.101 | 3.101 | 2.891 |
| Dec 16, 2024 | 3.011 | -0.290 | -8.79% | 3.301 | 3.301 | 2.921 |
| Dec 13, 2024 | 3.091 | -0.160 | -4.92% | 3.251 | 3.251 | 3.071 |
| Dec 12, 2024 | 3.231 | -0.090 | -2.71% | 3.321 | 3.391 | 3.161 |
| Dec 11, 2024 | 3.381 | 0.030 | 0.90% | 3.351 | 3.421 | 3.351 |
| Dec 10, 2024 | 3.361 | 0.120 | 3.70% | 3.241 | 3.421 | 3.131 |
| Dec 9, 2024 | 3.441 | 0.280 | 8.86% | 3.161 | 3.481 | 3.131 |
| Dec 6, 2024 | 3.121 | 0.060 | 1.96% | 3.061 | 3.221 | 3.021 |
| Dec 5, 2024 | 3.081 | -0.060 | -1.91% | 3.141 | 3.181 | 3.061 |
| Dec 4, 2024 | 3.111 | -0.050 | -1.58% | 3.161 | 3.161 | 3.031 |
| Dec 3, 2024 | 3.211 | 0.040 | 1.26% | 3.171 | 3.251 | 3.111 |
| Dec 2, 2024 | 3.181 | -0.170 | -5.07% | 3.351 | 3.351 | 3.151 |
| Nov 29, 2024 | 3.241 | -0.080 | -2.41% | 3.321 | 3.381 | 3.241 |
| Nov 27, 2024 | 3.251 | -0.090 | -2.69% | 3.341 | 3.341 | 3.251 |
| Nov 26, 2024 | 3.271 | -0.070 | -2.10% | 3.341 | 3.401 | 3.231 |
| Nov 25, 2024 | 3.321 | 0.110 | 3.43% | 3.211 | 3.391 | 3.131 |
| Nov 22, 2024 | 3.231 | -0.070 | -2.12% | 3.301 | 3.361 | 3.221 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Soligenix, Inc. Company profile
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301, a novel photodynamic therapy, which has completed Phase 3 clinical trial to treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase 3 clinical trial to treat oral mucositis in head and neck cancer. This segment also offers proprietary formulations of oral beclomethasone 17,21-dipropionate, which is in Phase 1/2 clinical trial for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation, including pediatric Crohn''s disease and acute radiation enteritis. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase 1a and 1b clinical trials; SGX943, a melioidosis therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic resistant and emerging infectious diseases; and ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.| Industry: | Bio Therapeutic Drugs |
Suite C-10
29 Emmons Drive
PRINCETON
NEW JERSEY 08540
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com